Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 10 member 5 (SLC10A5) is a predicted membrane transporter belonging to the solute carrier (SLC) family 10, which primarily mediates sodium-dependent transport of bile acids and related molecules. While SLC10A5 is classified as a bile acid:sodium symporter based on sequence homology and family characteristics, its endogenous substrates and specific transport functions remain undetermined. It is most highly expressed in the liver and kidney and is hypothesized to play a role in solute or bile acid transport, but direct experimental demonstration of its substrate specificity is lacking. No approved drugs are currently known to target this transporter, and its molecular and clinical significance is still under investigation. Gene associations have linked SLC10A5 with rare metabolic disorders, but detailed pathophysiological roles have yet to be conclusively established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 10 member 5 (SLC10A5).